Skip to main content
GO

Gunjan OHRI

Data Content Analyst, BioCentury

BioCentury

g***@biocentury.com Upgrade
Pro only
Chicago, United States

Industries

Recent Article

EMA’s CHMP snubs donanemab, even for APOE4 non-carriers

Upgrade for article links
292 total articles published · Analyst